Prognostic impact of natural killer cell count in follicular lymphoma and diffuse large B-cell lymphoma patients treated with immunochemotherapy.

CONCLUSION: These findings indicate that the number of NK cells in peripheral blood may affect the outcome of B-cell non-Hodgkin lymphoma patients receiving anti-CD20-based immunochemotherapy.
PMID: 31053601 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - May 2, 2019 Category: Cancer & Oncology Authors: Klanova M, Oestergaard MZ, Trněný M, Marcus R, Sehn LH, Vitolo U, Bazeos A, Goede V, Zeuner H, Knapp A, Sahin D, Bolen CR, Klein C, Venstrom J, Nielsen T, Fingerle-Rowson G Tags: Clin Cancer Res Source Type: research